Nephroblastoma: Does The Decrease In Tumour Volume Under Preoperative Chemotherapy Predict The Lymph Nodes Status At Surgery?

Similar documents
Università di Roma La Sapienza

Surgery for Wilms Tumour in Children in a Tertiary Centre in Hong Kong: A 15-year Retrospective Review

Intrarenal Extension. sinus

The management of bilateral Wilms tumor

Minimally invasive surgery in management of renal tumours in children

GUIDELINES ON RENAL CELL CANCER

Enterprise Interest Nothing to declare

PITFALLS AND TRAPS IN THE DIAGNOSIS AND STAGING OF RENAL TUMOURS OF CHILDHOOD. Gordan M. Vujanić Cardiff, U.K.

Wilms Tumour A brief note for the parents

All India Institute of Medical Sciences, New Delhi, INDIA. Department of Pediatric Surgery, Medical Oncology, and Radiology

GUIDELINES ON RENAL CELL CARCINOMA

Case 1. Clinical history

Wilms Tumor Outcomes at a Single Institution and Review of Current Management Recommendations

1. Sorbonne Universités, UPMC Univ Paris 06, APHP Hôpital Armand Trousseau Pediatric. Surgery, Research Unit St Antoine Inserm UMRS.

Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD

Children s Cancer and Leukaemia Group CLINICAL MANAGEMENT GUIDELINES WILMS TUMOUR. To be used in conjunction with IMPORT study protocol

MR Tumor Staging for Treatment Decision in Case of Wilms Tumor

Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav

Wilms Tumor and Neuroblastoma

Meta-analysis of the effect of preoperative chemotherapy on Wilms tumor

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management

Guidelines on Renal Cell

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Standards and datasets for reporting cancers. Dataset for histopathological reporting of renal tumours in childhood. November 2018

Prognostic Factors and Outcome of Wilms' Tumour in a Tertiary Children's Hospital, China

New Treatment Concepts in Pediatric Renal Tumors

Surgical Management of Renal Cancer. David Nicol Consultant Urologist

Why Do Axillary Dissection? Nodal Treatment and Survival NSABP B04. Revisiting Axillary Dissection for SN Positive Patients

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

Renal Parenchymal Neoplasms

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

Multidisciplinary Approach to Wilms Tumor: A Retrospective Analytical Study of 53 Patients

Surgical strategies to improve results in retroperitoneal sarcoma. Christoph Kettelhack University Hospital Basel

Dr Marty Campbell Paediatric Oncologist Royal Children's Hospital, Melbourne. FRACP lecture series Oct 2014

1 Department of Epidemiology and Cancer Control, St. Jude Children s. 4 Midwest Children s Cancer Center at Children s Hospital of

Indications For Partial

Evaluation of renal tumors in children

Protocol applies to specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood.

WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?

BILATERAL TERATOID WILMS TUMOR IN A CHILD: A CASE REPORT AND REVIEW OF LITERATURE ABSTRACT

Gerard M. Doherty, MD

Wilms tumor accounts for 90% of all malignant renal tumors of

WILMS TUMOR. Click to edit Master subtitle style. Dr.S.G.RAMANAN M.D,D.M MCCF, CRRT

Surgical Considerations in Breast Cancer treated with Neoadjuvant Therapy

University of Colorado Health Sciences Center, Denver Colorado ******************** ******************

Management of Rare Liver Tumours

SIOP PODC WILMS TUMOUR-1 Protocol

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

Surgical Advances in the Treatment of Breast Cancer. Laura Kruper, MD, MSCE Chief, Breast Surgery

When to Integrate Surgery for Metatstatic Urothelial Cancers

Renal Cancer. By Jamie Calderwood

Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report

Etiopathological and management profile of Wilms tumour A single centre experience

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

CONSENSUS STATEMENT 1

IVC THROMBECTOMY: OPEN

HISTORY SURGERY FOR TUMORS WITH INVASION OF THE APEX 15/11/2018

PDF created with pdffactory Pro trial version

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

Adult Wilms tumor diagnosis and current therapy

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma

EAU GUIDELINES ON RENAL CELL CARCINOMA

Complex case Presentations

Combined Modality Therapy of Pediatric Wilms' Tumor in Upper Egypt: A Retrospective Study

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Tratamiento adyuvante y neoadyuvante del cáncer renal en Xavier Garcia del Muro Solans Institut Català d Oncologia Hospitalet.

Objectives. Intraoperative Consultation of the Whipple Resection Specimen. Pancreas Anatomy. Pancreatic ductal carcinoma 11/10/2014

Late recurrence in children with Wilms tumor

Initial Surgery in Tailoring Treatment for Children With Stage II and III Wilms Tumor: An Experience From Resource Challenged Settings

Urological Tumours 1 Kidney tumours 2 Bladder tumours

Trimodality Therapy for Muscle Invasive Bladder Cancer

Renal Mass Biopsy: Needed Now More than Ever

Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard

Challenges in RCC surgery. Treatment Goals. Surgical challenges. Management options in VHL associated RCCs

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Isolated Hemihyperplasia in an Infant: An Overlooked Sign for Wilms Tumor Development

Urology An introduction to cut up DR J R GOEPEL

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Pancreatic Adenocarcinoma

Some Seminal Studies. Chemotherapy Alone is Inadequate. Bladder Cancer Role of Radiation in Bladder Sparing. Primary Radiation for Bladder Cancer

L impatto dell imaging sulla definizione della strategia terapeutica

RENAL CANCER GUIDELINES

Pediatric Retroperitoneal Masses Radiologic-Pathologic Correlation

SAMPLING OF POST NEPHRECTOMY CANCER CARE (5)

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

Renal Function Adaptation up to the Fifth Decade After Treatment of Children With Unilateral Renal Tumor: A Cross-Sectional and Longitudinal Study

Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine

Clinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy

Renal tumors of adults

The Role of Sentinel Lymph Node Biopsy and Axillary Dissection

RAPN. in T1b Renal Masses? A. Mottrie. G. Denaeyer, P. Schatteman, G. Novara

Renal tumors are among the most common

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Staging and Grading Last Updated Friday, 14 November 2008

TREATMENT OF PERITONEAL COLORECTAL CARCINOMATOSIS

Biliary tree dilation - and now what?

Transcription:

Nephroblastoma: Does The Decrease In Tumour Volume Under Preoperative Chemotherapy Predict The Lymph Nodes Status At Surgery? Jan Godzinski,, Harm van Tinteren,, Jan de Kraker,, Norbert Graf, Christophe Bergeron, Hugo Heij,, Dietrich von Schweinitz, Joerg Fuchs, Giovanni Cecchetto,, George Audry,, Frederic Gauthier, Bengt Sandstedt for the SIOP Nephroblastoma Trial and Study Committe

conflict of interest disclosure for SIOP Boston 2010 there were no financial support for this study Jan Godzinski

- who knows how to wake-up the anaesthesiologist?

SIOP ignores initial staging (but IV and V) the treatment is based on the surgical/pathological status assessed at surgery after preop. ChT marked decrease of tumor volume suggests that the tumour variant is chemosensitive and practically excludes anaplastic WT Decrease of tumor volume induced by the preoperative ChT is observed in 82% of pts Median Vol. decrease = 65% High proportion of stage 1 patients (54%) and nearly 100% OS these pts less aggressive surgery in case of favorable location? 1360 pts with unilateral, localized nephroblastoma and sufficient data from SIOP 9301

SIOP ignores initial staging (but IV and V) the treatment is based on the surgical/pathological status assessed at surgery after preop. ChT marked decrease of tumor volume suggests that the tumour variant is chemosensitive and practically excludes anaplastic WT Decrease of tumor volume induced by the preoperative ChT is observed in 82% of pts Median Vol. decrease = 65% High proportion of stage 1 patients (54%) and nearly 100% OS these pts less aggressive surgery in case of favorable location? 1360 pts with unilateral, localized nephroblastoma and sufficient data from SIOP 9301

SIOP ignores initial staging (but IV and V) the treatment is based on the surgical/pathological status assessed at surgery after preop. ChT marked decrease of tumor volume suggests that the tumour variant is chemosensitive and practically excludes anaplastic WT Decrease of tumor volume induced by the preoperative ChT is observed in 82% of pts Median Vol. decrease = 65% High proportion of stage 1 patients (54%) and nearly 100% OS these pts less aggressive surgery in case of favorable location? 1360 pts with unilateral, localized nephroblastoma and sufficient data from SIOP 9301

Selected reports advocating feasablity and benefits of nephrone sparing surgery in unilateral nephroblastoma (1989-2006) 1.Gentil Martins A, Espana M (1989) Partial nephrectomy for nephroblastoma a plea for less radical surgery. Med Pediatr Oncol 17: 320 2.Moorman-Voestermans CGM, Staalman CR, Delamarre JFM. Partial nephrectomy in unilateral Wilms tumour is feasible without local recurrence. Med. Pediatr Oncol 23: 218, 1994 3.Moorman-Voestermans CGM, Aronson DE.C. Staalman CR, Delamarre JFM., De Kraler J. Is partial nephrectomy appropriate treatment for unilateral Wilms tumour? J Ped Surg., 33: 165-170, 1998 4.Cozzi DA, Schiavetti A, Morini F, Castello MA, Cozzi F. Nephron sparing surgery for unilateral primary renal tumor in children. J Pediatr Surg, 36, 2: 362-365, 2001 5.Hoellwarth ME, Urban C, Linni K, Lackner H. Partial nephrectomy in patients with unilateral Wilms tumor. 3rd International Congress of Paediatric Surgery, Brussels, 6-8.05.1999, abstract book 6.Cozzi F, Cozzi DA., Schiavetti A., Zani A., Spagnol L., Totonelli G., Nephron-sparing surgery in children with unilateral renal tumour: a systematic literature review. Pediatric Blood & Cancer; Vol. 47; 4, October 1, 2006; 360 7.Cozzi DA, Zani A (2006) Nephron-sparing surgery in children with primary renal tumor: indications and results. Semin Pediatr Surg. 15: 3-9

nephrone sparing surgery (NSS) is not associated with elevetaed risk of relapse in case of stage 1 int. and low risk WT (no relapses in 18 stage 1 pts, SIOP 2001)* *Tuebingen 2007 and EUPSA 2008

How to predict stage prior to surgery? good quality imaging may reliably suggest the staging. the LN status, however, remains obscure (no evidence based data) 1, 2. Note 1: tumor positive LN s imply radiotherapy, which counteracts the functional benefits of NSS Note 2: frozen-section of the LN s as the first step of surgery (before NSS is finally aproved) is considered not reliable enough

hypothesis SIOP ignores initial staging (but IV and V) the treatment is based on the marked decrease of surgical/pathological status suggests that the assessed at surgery after risk), thus also LN preop. ChT marked decrease of tumor volume suggests - if also imaging that the tumour variant tumour, iswithout chemosensitive renal vessels and practically with excludes anaplastic WT choice NSS is not associated with elevetaed risk of relapse in case of stage 1 int. and low risk WT (no relapses in 18 under stagepreop. 1 pts, ChT SIOP 2001) of tu volume under the tumour is chemosensitive (low or int LN s, even if initially invaded, shall be cleared of tumour cells. good quality imaging may reliably suggest the staging, but LN status remains obscure (no evidence based data) imaging suggests stage 1, polar or peripheral without invasion of the collective system & with > ½ of the kidney procedure of choice kidney doesfree the decrease NSS is of tumor volume under ChT predict the LN status at surgery?

The aim of this report is to verify whether marked decrease of tumour volume under preoperative chemotherapy, indicating chemosensitivity, also implies clearance of the regional LN

1: tu size at dgn 2: tu size after 4-week VA approx. 80% decrease in tumor volume 3: sampling the LN s at nephrectomy, none of 6 sampled nodes invaded

Patients: SIOP 9301 (1993-2001): 1450 localized WT 1360 (93%) had sufficient data. Patients were divided in: these with tumor positive LN (76 (5.5%)) at surgery those with tumour negative LN (1284 (94.5%)) at surgery.

LN- =1284 LN+ = 76 N=1360 p value Gender male 572 (45%) 35 (46%) 607 (45%) chisq P=0.798 female 712 (55%) 41 (54%) 753 (55%) Side right 612 (48%) 25 (33%) 637 (47%) chisq P=0.033 left 626 (49%) 44 (58%) 670 (49%) Missing 46 (4%) 7 (9%) 53 (4%) Stage I 729 (57%) 730 (54%) fisher P=<.001 II 419 (33%) 5 (6%) 424 (31%) III 136 (11%) 71 (93%) 207 (15%) Risk low risk 72 (6%) 2 (3%) 74 (5%) fisher P=0.195 intermediate risk 1127 (88%) 65 (86%) 1192 (88%) high risk 84 (7%) 9 (12%) 93 (7%) nephrogenic rest 1 (0.1%) 1 (0.1%)

LN- =1284 LN+ = 76 N=1360 p value Gender male 572 (45%) 35 (46%) 5.5% 607 (45%) chisq P=0.798 female 712 (55%) 41 (54%) 753 (55%) Side right 612 (48%) 25 (33%) 637 (47%) chisq P=0.033 left 626 (49%) 44 (58%) 670 (49%) Missing 46 (4%) 7 (9%) 53 (4%) Stage I 729 (57%) 730 (54%) fisher P=<.001 II 419 (33%) 5 (6%) 424 (31%) III 136 (11%) 71 (93%) 207 (15%) Risk low risk 72 (6%) 2 (3%) 74 (5%) fisher P=0.195 intermediate risk 1127 (88%) 65 (86%) 1192 (88%) high risk 84 (7%) 9 (12%) 93 (7%) nephrogenic rest 1 (0.1%) 1 (0.1%)

Continuous measures by LN status N- N+ p Vol at dgn (ml) 377 (200-622) 554 (318-772) 0.00091 Vol at surg (ml) 130 (44-294) 192 (63-458) 0.05553 Vol change (%) 62 67 0.04620 Vol increase (pts) 115 9 0.6199 Vol decrease (pts) 770 39 0.037 The variables have been tested within the different groups (multiple testing problem) the actual p-value p of 0.05 can no longer be used as a threshold. Rather, p-values p of <0.01 should be considered significant.

Continuous measures by LN status N- N+ p Vol at dgn (ml) 377 (200-622) 554 (318-772) 0.00091 Vol at surg (ml) 130 (44-294) 192 (63-458) 0.05553 Vol change (%) 62 67 0.04620 Vol increase (pts) 115 9 0.6199 Vol decrease (pts) 770 39 0.037 The variables have been tested within the different groups (multiple testing problem) the actual p-value p of 0.05 can no longer be used as a threshold. Rather, p-values p of <0.01 should be considered significant.

Boxplot figures of (A) tu volume at dgn (Ultrasound), (B) tu vol. at surgery, (C) difference in tu vol. and (D) percentage change in volume ume. All localized patients and pathological confirmed LN-status. A B 0 500 1500 2500 0 500 1000 1500 LN- LN+ LN- LN+ C NS D -1000 0 1000 3000-250 -150-50 0 50 LN- LN+ LN- LN+

on what to build the guidelines? initial tumour volume was significantly larger in LN(+) patients; p=0,00091; Krusk. (but not different (NS) at surgery) rate of LN(+) patients was low (5.5%) please note : not a single case of LN involvement if initial volume < 318 ml

Conclusions: Change in tumour volume under preoperative chemotherapy is not a predictor for LN status at surgery, although larger initial volume is associated with a higher risk of LN invasion after preoperative ChT. The decrease of tumour volume is not a good criterium for the safety of NSS. The low rate of positive LN (5.5%) in the whole group indicates that this risk should not be overestimated, especially if the patients with a small initial tumour volume are considered for NSS (not a single case of LN involvement if initial volume below 318 ml.)

Candidates for NSS according to SIOP 2001 Those who had no: pre-operative tumor rupture or biopsy infiltration of the extra renal structures intra-abdominal metastases or lymph nodes seen on pre-operative imaging thrombus in the renal vein or vena cava tumour involving more than 1/3 of the kidney multifocal or central tumour, involvement of calyces, haematuria little experience in partial nephrectomy. other low staged polar or peripheral tumours were potential candidates for NSS.

what is really required?

1. WT with initial volume < 300 ml 2. Imaging prior to surgery: polar or peripheral tumour no extra renal invasion collective system and renal vessels free and no unfortunate events as ruptures, open biopsies etc

all the other other unilateral cases are not candidates for NSS